Related Experiment Video
Updated: Jul 18, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the
S Kyun Lim1, F Michael Hoffmann
1McArdle Laboratory for Cancer Research and Laboratory of Genetics, University of Wisconsin, Madison, WI 53706, USA.
Abstract:
The c-myc protooncogene is a key regulator of cell proliferation whose expression is reduced in normal epithelial cells in response to the growth inhibitory cytokine TGF-beta. Smad4 mediates this inhibitory effect of TGF-beta by forming a complex with Smad3, E2F4/5, and p107 at the TGF-beta inhibitory element (TIE) element on the c-myc promoter. In contrast, cell proliferation and c-myc expression are increased in response to Wnt ligands; this effect is mediated through the lymphoid enhancer-binding factor 1/T cell-specific factor (LEF/TCF) family of transcription factors on the c-myc promoter LEF/TCF-binding elements (TBE1 and TBE2). We report that a peptide aptamer designed to inhibit the binding between Smad4 and LEF/TCF reduced c-myc expression and the growth rate of HepG2 cells. Further analysis demonstrated that, in the absence of TGF-beta, Smad4 was bound to the positive regulatory element TBE1 from the c-myc promoter and activated c-myc promoter activity. Smad4 binding to the positive TBE1 c-myc element was reduced by TGF-beta, consistent with Smad4's inhibitory role on c-myc expression in response to TGF-beta. Reduction of Smad4 levels by RNAi knockdown also reduced c-myc expression levels and sensitized hepatocytes to cell death by serum deprivation. Two tumor-derived mutant Smad4 proteins that fail to mediate TGF-beta responses were still competent to cooperate with LEF1 to activate the c-myc promoter. These results support a previously unreported TGF-beta-independent function for Smad4 in cooperating with LEF/TCF to activate c-myc expression.
Insights
Smad4 activates c-myc expression and cell growth independently of TGF-beta by binding to promoter elements. Inhibiting Smad4-LEF/TCF interaction reduces c-myc and cell proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The c-myc protooncogene regulates cell proliferation.
- Transforming growth factor-beta (TGF-beta) inhibits c-myc expression in epithelial cells.
- Wnt ligands promote c-myc expression and cell proliferation.
Purpose of the Study:
- To investigate the role of Smad4 in regulating c-myc expression.
- To explore the interaction between Smad4 and Wnt signaling pathway components.
- To determine the TGF-beta-independent functions of Smad4 in c-myc regulation.
Main Methods:
- Peptide aptamer inhibition of Smad4-LEF/TCF binding.
- RNA interference (RNAi) for Smad4 knockdown.
- Analysis of c-myc promoter activity and gene expression.
- Assessment of cell proliferation and cell death.
Main Results:
- A peptide aptamer targeting Smad4-LEF/TCF interaction reduced c-myc expression and HepG2 cell growth.
- Smad4 binds to the TBE1 element of the c-myc promoter, activating its activity independently of TGF-beta.
- TGF-beta reduces Smad4 binding to TBE1, consistent with its inhibitory role.
- Smad4 knockdown reduced c-myc levels and sensitized cells to serum deprivation-induced death.
- Tumor-derived Smad4 mutants retained the ability to activate c-myc with LEF1.
Conclusions:
- Smad4 possesses a novel TGF-beta-independent function in activating c-myc expression.
- Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor (LEF/TCF) to promote c-myc expression and cell growth.
- Targeting the Smad4-LEF/TCF interaction may offer therapeutic strategies for cancers driven by aberrant c-myc expression.
Related Concept Videos
TGF - β Signaling Pathway
Master Transcription Regulators
Somatic to iPS Cell Reprogramming
Induced Pluripotent Stem Cells
Somatic cells are...
Co-activators and Co-repressors
Abnormal Proliferation

